Lv5
1100 积分 2024-04-14 加入
Immunotherapy Response in Microsatellite Instability–High Gastroesophageal Adenocarcinoma
1个月前
已完结
Lenvatinib, sintilimab plus transarterial chemoembolization for advanced stage hepatocellular carcinoma: A phase II study
1个月前
已完结
Efficacy and safety of surufatinib and sintilimab with or without chemotherapy for advanced high-grade neuroendocrine neoplasms and pancreatic cancer
1个月前
已完结
Safety and efficacy of intratumoural anti-CTLA4 with intravenous anti-PD1
2个月前
已完结
Maintenance Therapy for Recurrent or Metastatic Cervical Cancer: A Multicenter, Cohort Study
4个月前
已完结
Neoadjuvant Chemotherapy With CAPOX Versus Chemoradiation for Locally Advanced Rectal Cancer With Uninvolved Mesorectal Fascia (CONVERT): Final Results of a Phase III Trial
5个月前
已完结
No correlation between MASLD and poor outcome of Atezolizumab‐Bevacizumab therapy in patients with advanced HCC
6个月前
已完结
Efficacy and safety of immune checkpoint inhibitors for individuals with advanced EGFR-mutated non-small-cell lung cancer who progressed on EGFR tyrosine-kinase inhibitors: a systematic review, meta-analysis, and network meta-analysis
6个月前
已完结
Total neoadjuvant therapy followed by non-operative management or surgery in stage II–III rectal cancer (NO-CUT): a multicentre, single-arm, phase 2 trial
7个月前
已完结
Sintilimab combined with bevacizumab in relapsed or persistent ovarian clear cell carcinoma (INOVA): a multicentre, single-arm, phase 2 trial
8个月前
已完结
皖公网安备34019202002308
